Hungarian scientists have discovered that DMT, a potent psychoactive molecule naturally produced in the human pineal gland and found throughout plant life, can significantly reduce the harmful effects of stroke in animal models and cell culture experiments. The research team led by Professor Mária Deli, Professor Zoltán Nagy, and Dr. Sándor Nardai found that DMT treatment restored the structure and function of the damaged blood-brain barrier in mice that had suffered strokes, improved astrocyte function, inhibited inflammatory cytokine production, and significantly reduced infarct volume and brain swelling. Published in the journal Science Advances, the breakthrough research offers a dual-action approach that protects the blood-brain barrier while reducing brain inflammation, something that could complement existing treatments which currently have very limited success in achieving full recovery.
Co-first author Judit Vigh explains that current therapeutic options for stroke are extremely limited, making this novel complex approach particularly promising as around 800,000 strokes occur annually in the US alone, with costs reaching $56 billion and stroke accounting for one in six cardiovascular disease deaths. Clinical trials have already begun abroad with investigations into the long-term effects of DMT currently ongoing, though there’s still a long way to go before it reaches everyday medicine as most European countries including Hungary consider DMT a controlled hallucinogen under strict criminal laws. The recent findings from researchers in Szeged and Budapest support developing a therapy that goes beyond the limitations of conventional stroke treatment, potentially offering hope to millions who face devastating brain damage. This naturally occurring compound that your body already produces may hold the key to protecting brains during one of medicine’s most time-sensitive emergencies, proving that sometimes the most powerful medicines are already inside us.
